Scarica l'app Stockscreener
4.27
1.61%
-0.07
Dopo l'orario di chiusura:
4.27
Precedente Chiudi:
$4.34
Aprire:
$4.25
Volume 24 ore:
139.31K
Relative Volume:
0.65
Capitalizzazione di mercato:
$249.88M
Reddito:
$33.48M
Utile/perdita netta:
$-52.70M
Rapporto P/E:
-3.3129
EPS:
-1.2889
Flusso di cassa netto:
$-49.45M
1 W Prestazione:
-4.90%
1M Prestazione:
-2.51%
6M Prestazione:
+59.33%
1 anno Prestazione:
+21.31%
Intervallo 1D:
$4.09
$4.39
Intervallo di 1 settimana:
$4.04
$4.49
Portata 52W:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Nome
Orchestra Biomed Holdings Inc
Settore
Industria
Telefono
646-343-9298
Indirizzo
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.27 | 249.88M | 33.48M | -52.70M | -49.45M | -1.2889 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Iniziato | TD Cowen | Buy |
| 2025-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-03-20 | Iniziato | BTIG Research | Buy |
| 2025-01-02 | Iniziato | Barclays | Overweight |
| 2024-08-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | B. Riley Securities | Buy |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2023-02-24 | Iniziato | Piper Sandler | Overweight |
| 2023-02-07 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
If You Invested $1,000 in Orchestra BioMed Holdings Inc (OBIO) - Stock Titan
Orchestra Biomed Holdings Inc (NASDAQ:OBIO) Fits the Minervini High-Growth Momentum Template - ChartMill
Aug Fed Impact: What is Orchestra BioMed Holdings Incs 5 year growth outlook - baoquankhu1.vn
Activity Recap: Does Orchestra BioMed Holdings Inc outperform in volatile markets2026 Market WrapUp & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Analyst Upgrade: How much upside does Orchestra BioMed Holdings Inc have2026 Chart Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn
Orchestra BioMed reports 2025 results, advances pivotal clinical trials - MSN
Orchestra BioMed (NASDAQ: OBIO) insider reports RSU tax withholding event - Stock Titan
Orchestra BioMed (OBIO) officer has shares withheld for RSU tax payment - Stock Titan
Orchestra BioMed (OBIO) insider withholds 32,438 RSU shares for tax - Stock Titan
Jefferies cuts Orchestra BioMed stock price target on financing costs By Investing.com - au.investing.com
Stock Report: Does Orchestra BioMed Holdings Inc outperform in volatile markets2026 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Orchestra BioMed (OBIO) to Release Earnings on Wednesday - MarketBeat
Trend Report: How do insiders feel about Orchestra BioMed Holdings IncRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Analysts’ Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH) - The Globe and Mail
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aug Highlights: Will Orchestra BioMed Holdings Inc benefit from geopolitical trends2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
HC Wainwright Has Optimistic Outlook of OBIO Q1 Earnings - MarketBeat
Orchestra BioMed Reports 2025 Results, Advances Pivotal Clinical Trials - MyChesCo
Top Executive Makes Bold Insider Move at Orchestra BioMed - TipRanks
Orchestra BioMed (NASDAQ:OBIO) Insider Purchases 10,000 Shares - MarketBeat
Orchestra BioMed (OBIO) director David Hochman buys 10,000 shares - Stock Titan
Orchestra BioMed (OBIO) First Profitable Quarter Tests Bearish Unprofitability Narrative - simplywall.st
Orchestra BioMed (NASDAQ:OBIO) Raised to Hold at Wall Street Zen - MarketBeat
Orchestra BioMed Holdings (OBIO) Receives a Buy from Chardan Capital - The Globe and Mail
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - Sahm
Orchestra BioMed Holdings, Inc. (OBIO) surpasses Q4 earnings and revenue estimates - MSN
Orchestra BioMed (NASDAQ:OBIO) Receives "Buy" Rating from Chardan Capital - MarketBeat
Chardan reiterates Orchestra BioMed stock rating on trial focus By Investing.com - Investing.com Canada
Chardan reiterates Orchestra BioMed stock rating on trial focus - Investing.com
Orchestra BioMed Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Orchestra BioMed Holdings, Inc. (OBIO) Exceeds Expectations for Q4 Earnings and Revenue - Bitget
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
OBIO: Revenue up 1,539% to $33.5M; strong cash, pivotal trials advancing, more proceeds expected - TradingView
Orchestra BioMed Reports $106.5 Million Cash Position and Major Financial Milestones for 2025 - Quiver Quantitative
Orchestra BioMed Holdings 10-K Summary — Revenue: $— | EPS: $— - TradingView
Orchestra BioMed Secures $30 Million Terumo Deal for Coronary Device Rights - MSN
Aug Analyst Calls: Will Orchestra BioMed Holdings Inc benefit from AI trendsTrade Risk Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Why Orchestra BioMed Holdings Inc. stock could outperform in 2026Portfolio Update Report & Risk Managed Trade Strategies - Naître et grandir
Insider Sell: How resilient is Orchestra BioMed Holdings Inc. stock in market downturns2025 Key Highlights & Verified Short-Term Trading Plans - Naître et grandir
Orchestra BioMed Holdings Inc. share price - Mint
Market Leaders: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Orchestra BioMed to present hypertension therapy data at medical meetings By Investing.com - Investing.com Canada
Orchestra BioMed announces presentations highlighting Avim therapy potential impact on hypertensive heart disease and heart failure at THT and CRT - marketscreener.com
Orchestra Biomed Holdings Inc Azioni (OBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):